Retinal Neuroaxonal Loss Detectable With Epilepsy
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 17, 2024 -- In people with epilepsy, progression of retinal neuroaxonal loss is detectable at short-term follow-up, according to a study published online Oct. 9 in Epilepsia.
Livia Stauner, from LMU University Hospital in Germany, and colleagues examined the longitudinal dynamics of retinal neuroaxonal loss and possible driving factors in 44 people with epilepsy versus 56 healthy controls (aged 18 to 55 years) who underwent spectral domain optical coherence tomography.
The researchers found a significant decrease in the peripapillary retinal nerve fiber layer (pRNFL), macular RNFL, ganglion cell inner plexiform layer (GCIP), and total macular volume thickness or volume over 7.0 months in people with epilepsy. The annualized percentage change of the pRNFL (−0.98/year) and the GCIP (−1.24/year) were significantly more pronounced in people with epilepsy versus controls. Atrophy of the macular RNFL was significantly influenced by the number of antiseizure medications and increasing age of people with epilepsy. However, contradictory results were seen for the impact of seizures.
“People with epilepsy who receive a high number of antiseizure medications seem to be at risk for accelerated neuroaxonal loss, stressing the importance of well-considered and effective antiseizure therapy,” write the authors.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Helping Others Linked to Higher Level of Cognitive Function
THURSDAY, Aug. 21, 2025 -- Helping others, both via formal volunteering and informal helping, is associated with higher levels of cognitive function and slower cognitive decline...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 -- Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.